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Tricuspid annular motion is used to estimate biventricular function but is limited by its
angle dependency. Two-dimensional speckle tracking echocardiography (STE), an angle-
independent technique, may provide a more objective assessment. The objective of our
study was to investigate the role of STE-based tricuspid annular displacement (TAD) in
evaluating biventricular function. A total of 106 patients with heart failure were divided
into three groups categorized by global left ventricular (LV) ejection fraction and 20 normal
subjects served as the control group. TAD was assessed by STE in both the right ventricu-
lar septal and free wall annulus from the four-chamber view. Parameters including LV vol-
ume, peak systolic tricuspid annular velocity, right ventricular fraction area change and LV
mass were compared among different groups and correlated with TAD. TAD was linearly
correlated with peak systolic tricuspid annular velocity (free wall annulus, r = 0.58; septal
annulus, r = 0.69; both p < 0.0001) and right ventricular fraction area change (free wall
annulus, r = 0.70; septal annulus r = 0.79; p < 0.01). There was a graded decrease in TAD
among the different groups of heart failure patients categorized by worsening LV ejection
fraction. TAD was lower in patients with preserved LV ejection fraction heart failure com-
pared with that in the control group (p < 0.01). A negative linear correlation between LV
mass and TAD (free wall annulus, r = −0.35; septal annulus, r = −0.34; p < 0.01) was also
observed. TAD not only reflected biventricular systolic function but also appeared to be
inversely related to LV mass. Patients with heart failure symptoms with or without
impaired LV systolic function had a lower TAD when compared with normal individuals.
KEY WORDS — heart failure, peak systolic tricuspid annular velocity, speckle
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Introduction
Right ventricular (RV) systolic dysfunction in patients
with heart failure has been previously reported to be
a powerful predictor of both cardiovascular morbid-
ity and mortality [1–3]. Therefore, RV functional
assessment could be of significant clinical value. The
traditional method for RV functional evaluation by
calculating RV fractional area change (RVFAC) relies
on high image quality and is limited to images
with good endocardial border tracing. Additionally,
tricuspid annular motion, which is technically more
feasible and represents longitudinal RV contraction
[4–6], has recently been reported to represent
global RV function. Recently, accumulating data
have shown that both tricuspid annular plane sys-
tolic excursion (TAPSE) and peak systolic tricuspid
annular velocity (PSTAV) are attractive alternatives to
estimating RV performance with simplicity in clini-
cal practice [7]. Unfortunately, these modalities are
limited by their angle-dependency between cardiac
motion and the echo beam [8], leading to a possible
estimation error. Two-dimensional speckle tracking
echocardiography (STE), a new echocardiographic
technology based on gray-scale B-mode images, is
relatively angle-independent and may allow auto-
matic, objective assessment of myocardial function
using continuous frame-by-frame motion [9,10].
Use of tricuspid annular displacement (TAD) can be
easily quantified for assessment of longitudinal RV
function from the four-chamber view.
Interestingly, TAPSE has recently been shown to
reflect not only RV but also left ventricular (LV) func-
tional changes. Based on the theory of ventricular
interdependence, LV functional disturbance may at-
tenuate RV function [11–14]. Similarly, left ventricular
longitudinal function assessment based on mitral an-
nular motion is able to detect early deterioration of LV
function [15–17] before changes of ventricular dilata-
tion and remodeling [18]. However, it is unknown to
what extent ventricular dysfunction and clinical man-
ifestations have an impact on TAD. Therefore, we
investigated the role of TAD in patients presenting
with clinical heart failure symptoms with various
extents of ventricular systolic functional decay.
Materials and Methods
Patient population
This study comprised a total of 126 participants,
including 106 patients with symptoms (at least
New York Heart Association Functional class II) or
signs of heart failure (evidence of pulmonary con-
gestion/edema or lower leg edema by chest X-ray
or physical examination) from the outpatient clinics
of Mackay Memorial Hospital. The first group con-
sisted of 36 patients with a left ventricular ejection
fraction (LVEF) below 35% or LV end-diastolic diam-
eter greater than 55 mm (defined as the dilated car-
diomyopathy [DCM] group [19]); the second group
consisted of 30 patients with LVEF ranging from
35–49% (defined as the systolic heart failure [SHF]
group); the third group consisted of 40 patients
with LVEF greater or equal to 50% (defined as the
diastolic heart failure [DHF] group). Twenty normal
volunteers served as the control group. Baseline
demographics and medications were all obtained
from the medical records or by chart review. Patients
who underwent any valve replacement procedures
and those with tricuspid/pulmonary stenosis, tri-
cuspid regurgitation of at least a moderate degree
or significant other valve disease were excluded from
this study. All participants were in sinus rhythm.
Major cardiac arrhythmias that precluded steadily
analyzable tracking with various cycle lengths were
also excluded from this study. This study was ap-
proved by the Mackay Memorial Hospital, interna-
tional ethical review committees (MMH-I-S-626) and
all patients gave informed consent.
Traditional echocardiographic 
measurements
A cardiovascular ultrasound system (iE33; Philips,
Andover, Massachusetts, USA) equipped with a mul-
tiple frequency phased array S5 transducer (2.5–
4.0 MHz) was used in this study. All subjects were in
the left free wall decubitus position during echo-
cardiographic acquisition with the examination
protocol performed in accordance with the recom-
mendations of the American Society of Echocardio-
graphy [20]. LVEF was calculated using the Simpson’s
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rule algorithm from the apical four-chamber view
with the following formula: LVEF = [(LV end-diastolic
volume – LV end-systolic volume)/LV end-diastolic
volume] × 100%. LV mass was assessed by the fol-
lowing formula: LVmass (g) = 0.8 × {1.05 × [(LVID +
IVST + PWT)3 – (LVID)3]} + 0.6, where LVID is the left
ventricular internal dimension, IVST is the intraven-
tricular septum thickness and PWT is the posterior
wall thickness. Relative wall thickness was further
assessed by using the following equation: relative
wall thickness = (2 × PWT/LVID) × 100. Ventricular di-
astolic parameters including early mitral inflow
Doppler, late mitral inflow Doppler, deceleration
time of E (DT) and isovolumic relaxation time (IVRT)
were all obtained from the LV apical four-chamber
view with adequate settings.
Assessment of tricuspid annular displacement
and velocity
A novel tissue tracking commercialized software
(2DQ, QLab, version 6.0 or 7.0; Figure 53 LLC,
Baltimore, Maryland, USA) based on 2D (B-mode)
images was used to track TA motion in an off-line
fashion. We predefined the widest transverse axis of
TA and the longest longitudinal axis of RV on the
apical four-chamber view. The widest transverse
axis consisted of two points: one in the septal and
the other in the free wall aspects of the TA (Fig. 1).
Another point at the apical area of the RV was placed
at the longest distance vertical to the widest trans-
verse axis as possible. The landmarks were manu-
ally placed, followed by automatic frame-by-frame
tracking of TA throughout the whole cardiac cycle
by QLab software with the highest frames possible
(an average of more than 60 frames per second
[fps]). A color-encoded display of TA motion through
the whole systolic phase was then acquired with
quantitative analysis of longitudinal TA displace-
ment defined as TAD, presented as TMAD1 on the
free wall and TMAD2 on the septal aspect of TA
(Fig. 1). Similarly, PSTAV was obtained by utilizing
the Doppler myocardial imaging method includ-
ing that obtained from the basal segment from the
both free wall and septal aspect of the TA from the
apical four-chamber view with the highest frame
rates possible (average 80–120 fps). The ultrasound
beam was adjusted to parallel the cardiac long 
axis as much as possible. RVFAC was calculated in 
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Fig. 1. Automatic tracking with objective quantification of tricuspid annular displacement (TAD) by QLab software in both the
septum and free wall. (A) Upper plane shows a normal person and the TAD free wall aspect is presented as TMAD1 and the 
septal aspect is presented as TMAD2. (B) TAD in patients with diastolic heart failure, (C) systolic heart failure, and (D) dilated
cardiomyopathy.
35 randomly selected participants in our study
group according to the following equation as pre-
viously described [5]: RVFAC= [(RV end-diastolic – RV
end-systolic area)/RV end-diastolic area] × 100%.
Reproducibility
Repeated measurements of TAD from 20 randomly
selected participants in this study determined inter-
observer and intraobserver variability. Coefficient
of variation of 95% limits of agreement from the
Bland-Altman method were used for variability
analysis. Intraobserver variability was defined as the
mean of the absolute difference between two mea-
surements from a single observer on a given echo-
cardiography study. Interobserver variability was
similarly defined by using the difference between
measurements from two independent observers.
Statistical analysis
All data were analyzed using the statistical STATA
software program (Stata Corp., College Station,
Texas, USA). Continuous data were presented as
mean ± SD. Categorical data were reported as a
percentage and tested by the χ2 or Fisher’s exact
test as appropriate. Linear regression analysis was
performed to display the relationship between TAD
RVFAC and PSTAV. One-way analysis of variance was
used to compare the difference in variables among
groups; post hoc analysis was used for paired com-
parisons between each group. Any two-sided p
less than 0.05 was considered to be statistically
significant.
Results
Differences in ventricular structure and
baseline data between the groups
The demographic data of all participants are shown
in Table 1. No significant differences in age and 
sex were observed among the four groups. Para-
meters with respect to LV function and LV mass
measurements are also displayed in Table 1. The
average blood pressure, either systolic or diastolic,
was higher in the heart failure groups compared
with the control group (all p < 0.05). In addition,
there was a significant increase in the thickness of
the LV posterior wall and septum in patients with
DHF compared with the control group. Similarly,
the thickness of the LV posterior wall and septum in
DHF group was significantly greater than those of
the DCM group. Patients with DCM had the largest
LV end-diastolic volume and the lowest LVEF. In
patients with DHF, LV end-diastolic volume and ejec-
tion fraction were not significantly different com-
pared with those of the control group. Moreover, in
patients with SHF, the mean LV end-diastolic volume
and LVEF values were in between the DHF and DCM
groups, suggesting a graded decrease in LVEF and
an increase in LV end-diastolic volume from the
DHF to the DCM group (p < 0.05). There was a sig-
nificantly larger LV mass in patients with DCM and
SHF compared with the DHF and control subjects.
Diastolic parameters including mitral inflow DT
and IVRT were also significantly different among
the groups, with a shorter DT in the SHF and DCM
groups compared with the other groups. In addi-
tion, a significantly graded decrease of IVRT was
observed from the control to the DHF, SHF to
DCM groups.
Validation and correlation among TAD,
RVFAC, and PSTAV
The values of TAD and PSTAV of the four groups are
shown in Table 2. There were significant differences
in TAD and PSTAV among the four groups (p< 0.001
for both the septal and free walls). However, there
was no significant difference in TAD between the
DCM and SHF groups (post hoc test, p = 0.582 for
the septal wall and p = 0.325 for the free wall). As
expected, septal PSTAV showed no significant dif-
ference between the DCM and SHF groups (post
hoc test, p = 0.529). Unexpectedly, there was a sig-
nificant difference in lateral PSTAV between these
two groups (post hoc test, p = 0.007).
There was a strong linear correlation between
RVFAC and TAD (septum, r = 0.79; p = 0.0008; free
wall, r = 0.70; p = 0.006). In addition, TAD had a
strong correlation with PSTAV (free wall, r = 0.58;
septum, r = 0.69, both p < 0.0001; Fig. 2).
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Table 1. Comparison of participants demographics, parameters on left ventricular (LV) function and mass
Groups
Heart failure Control
DCM (n = 36) SHF (n = 30) DHF (n = 40) (n = 20)
p
Sex (M/F) (%) 67.6/32.4 55.2/44.8 55.3/44.7 38.4/61.5 NS
Age (yr) 67.1 ± 16.0 66.6 ± 15.0 63.5 ± 13.0 61.5 ± 8.0 NS
SBP 136.7 ± 19.1 141.9 ± 23.3 139.1 ± 18.7 121.5 ± 11.4 p < 0.05*†‡
DBP 79.5 ± 12.3 82.7 ± 12.8 81.2 ± 12.2 67.3 ± 11.7 p < 0.05*†‡
LV echo parameter
PW (cm) 1.0 ± 0.2 1.1 ± 0.2 1.2 ± 0.2 1.0 ± 0.1 p = 0.007*, p = 0.01
IVS (cm) 1.1 ± 0.2 1.1 ± 0.2 1.1 ± 0.2 1.0 ± 0.1 p = 0.05*
LVIDd (cm) 5.9 ± 0.8 5.6 ± 1.1 4.9 ± 0.7 4.8 ± 0.4 p = 0.02†, p < 0.0001‡, 
p = 0.002§
LVEDV (mL) 178.5 ± 51.4 174.5 ± 79.6 117.6 ± 37.4 110 ± 20.8 p = 0.003†, p = 0.001‡,
p < 0.0001§
LVESV (mL) 124.6 ± 40.3 98.3 ± 48.6 47.9 ± 16.7 34.9 ± 10.6 p < 0.0001†‡§
p = 0.02¶
LVEF (%) 27.7 ± 5.9 42.2 ± 4.2 59.3 ± 5.6 68.9 ± 5.6 p < 0.0001†‡§¶
RWT (%) 38 ± 9.5 40 ± 6.5 43.5 ± 7.8 40.0 ± 6.5 p = 0.014
LV mass (g) 263.7 ± 79.2 270.4 ± 131.2 225.0 ± 90.6 164.6 ± 19.7 p = 0.007†, p = 0.01‡
E (cm/s) 86.1 ± 13.9 75.1 ± 18.2 64 ± 9.0 74.1 ± 13.5 p < 0.001
A (cm/s) 45 ± 17.2 58.4 ± 19.7 58.4 ± 19.7 64.9 ± 13.6 p = 0.005§, p = 0.011†,
p < 0.001
DT (ms) 147 ± 24.4 169.9 ± 23.4 226.9 ± 34.8 201.8 ± 19.7 p < 0.0001†‡§
IVRT (ms) 71±5.1 78.3±4.0 88.3±8.7 80.3±6.5 p=0.005*, p<0.0001†§,
p = 0.015¶
Medication history (%)
Hypertension 63.3 65 36.2 0 –
Diabetes 47.6 40 40 0 –
Coronary artery disease 67.3 65 33.3 0 –
Hyperlipidemia 27.6 30 26.7 0 –
NYHA Fc 2.7 2.6 1.6 0 –
Analysis of variance was used to compare the variables. *Differences between the control and DHF groups; †between the control and SHF groups;
‡between the control and DCM groups; §between the DHF and SHF groups; between the DHF and DCM groups; ¶between the SHF and DCM groups.
DCM = dilated cardiomyopathy; SHF = systolic heart failure; DHF = diastolic heart failure; SBP = systolic blood pressure; DBP = diastolic blood pressure;
LV = left ventricular; PW = posterior wall thickness; IVS = interventricular septum thickness; LVIDd = LV internal dimension measurement in diastole;
LVEDV = LV end diastolic volume; LVESV = LV end systolic volume; LVEF = LV ejection fraction; RWT = relative wall thickness; E = early diastolic mitral
inflow Doppler; A = late diastolic mitral inflow Doppler; DT = deceleration time of E wave; IVRT = iso-volumic relaxation time; NYHA Fc = New York
Heart Association Functional Class.
Relationship between TAD and LV structure
and function
A graded reduction of both TAD in the septal and
free walls was observed among the control, DHF,
SHF and DCM patient groups (trend, p<0.01, Fig. 3).
Patients with a lower LVEF had a lower value of
TAD (r = 0.68 vs. r = 0.61 for septal and free wall,
p < 0.001) and a lower value of PSTAV (r = 0.66 vs.
r = 0.57 for septal and free wall, p < 0.001). Although
there was no significant difference in LVEF between
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Fig. 2. (A,B) Correlation between tricuspid annular displacement (TAD), peak systolic tricuspid annular velocity (PSTAV) from
Doppler myocardial imaging. (C,D) Correlation between TAD and left ventricular (LV) mass. A good correlation between PSTAV
and TAD was observed on both the septum and free wall. In addition,there appeared to be an inverse relationship between LV mass
and TAD with a larger LV mass related to a reduction in TAD value. Moreover, persons with a lower LV ejection fraction (EF) also
seemed to have a lower TAD regardless of the LV mass from this scatter plot.
Table 2. Parameters of tricuspid annular displacement and velocity
Groups
DCM SHF DHF Control Analysis 
Post hoc p
(n = 36) (n = 30) (n = 40) (n = 20) of variance
TAD
Septal (mm) 5.3±0.4 6.4±0.4 11.4±0.4 14.3±0.6 F=32.59 p=0.001*, p<0.0001†‡§
p < 0.00001 p = 0.582¶
Free wall (mm) 10.0 ± 0.7 12.5 ± 0.9 18.1 ± 0.7 28.1 ± 1.7 F = 26.40 p < 0.0001*†‡§, 
p < 0.00001 p = 0.325¶
PSTAV
Septal (cm/s) 3.5 ± 0.2 4.7 ± 0.3 7.0 ± 0.3 7.5 ± 0.5 F = 50.33 p < 0.0001†‡§
p < 0.00001 p = 0.529¶
Free wall (cm/s) 7.2±0.5 9.7±0.7 12.2±0.3 12.5±0.5 F=14.22 p =0.002†, p <0.0001‡§,
p < 0.00001 p = 0.007¶
*Differences between the control and DHF groups; †between control and SHF group; ‡between the control and DCM groups; §between the DHF and SHF
groups; between the DHF and DCM groups; ¶between the SHF and DCM groups. DCM = dilated cardiomyopathy; SHF = systolic heart failure;
DHF = diastolic heart failure; TAD = tricuspid annular displacement; PSTAV = peak systolic tricuspid annular velocity.
the DHF and control groups, the DHF patients still
had a lower TAD value than did the control group
(septal wall, p=0.001; free wall, p<0.0001; Table 2).
Although patients with DCM had a smaller value
of TAD than the SHF group, there was no significant
difference in TAD between these groups (septal
wall, p = 0.582; free wall, p = 0.325; Table 2).
Linear regression analysis demonstrated a
strong negative correlation between TAD and LV
mass (septal wall, r=−0.34; free wall, r=−0.34; both
p < 0.0001; Fig. 2). Moreover, LV end-diastolic vol-
ume in each subject showed a significant negative
correlation with TAD (septal wall, r = − 0.41; free
wall, r = − 0.36; both p < 0.001). However, there was
no significant difference between TAD and relative
wall thickness. The intraobserver and interobserver
variability were less than 5%.
Discussion
Our study demonstrated that automatic TAD corre-
lated not only with RV function and systolic tricuspid
annular myocardial velocity, but correlated with LVEF.
It appears that LV structure and function may have an
impact on TAD. We found that while patients with
HF had a relatively preserved LVEF, they also had 
reduced TAD. A similar finding has been reported by
Lopez-Candales et al [13]. They demonstrated that
TAPSE is not only determined by RV systolic function
but also appears to depend on LV systolic function.
They also found that TAPSE < 2.0 cm was associated
with some degree of either RV or LV systolic dysfunc-
tion, whereas a value > 2.0 cm suggested normal bi-
ventricular systolic function. Previous studies [21]
using pulse-wave Doppler tissue imaging reported
that patients with congestive heart failure had signif-
icantly smaller tricuspid annular velocities compared
with healthy volunteers. Lamia et al [14] reported
that TAPSE was more strongly related to LVEF than to
indices of RV function in critically ill patients under
different fluid load or receiving inotropic status. They
concluded that a worse LV systolic function was asso-
ciated with a smaller value of TAD, which is com-
patible with poor RV function. We found that heart
failure patients with a preserved systolic function had
a mean free wall TAD of 18.1 mm and normal con-
trols was 28.1 mm. Furthermore, a mean free-wall
TAD of 10 mm or less was associated with severely
impaired LV function with generalized ventricular
chamber dilatation. As expected, we found that
patients with DHF had a smaller value of TAD than
control subjects despite no significant differences
in LVEF. This finding suggests that TAD may have the
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Fig. 3. A graded reduction of tricuspid annular displacement (TAD) from normal to heart failure patients with worsening left 
ventricular ejection fraction (LVEF) was observed. TAD was lower for patients with heart failure symptoms and preserved LVEF
when compared with the normal control group. There were no significant differences for TAD in the systolic heart failure (SHF) and
dilated cardiomyopathy (DCM) groups. DHF = diastolic heart failure.
potential to identify early-stage heart failure even
with preserved LVEF. Therefore, our data may help
to serve as a useful clinical reference relating TAD to
different stage LV functional changes and clinical
heart failure symptoms. Importantly, the parame-
ter TAD was not only angle-independent by 2D STE
but also was automatically calculated in a very short
time. This technique may potentially provide a more
rapid and feasible evaluation of biventricular func-
tion in patients with heart failure.
It is recently believed that ventricular geometric
alteration and remodeling, either on the left or right
side in terms of chamber dilatation, is considered
to confer prognostic value in patients with heart fail-
ure despite preserved or systolic dysfunction [22].
One of the most important issues of geometrical LV
remodeling is an increase in LV mid-cavity size, mass
and workload of the heart, which is then detrimen-
tal to cardiac function. Many studies have shown
that LV mass is a strong indicator for LV structural
alterations and a marker for LV remodeling, which
is associated with cardiovascular risks [23,24]. Our
data also demonstrated an inverse linear correlation
between TAD and LV mass where an increase in LV
mass was correlated with a decrease in TAD value.
Therefore, TAD appears to be associated with LV
structural alteration and the remodeling process,
and could reflect early cardiac damage.
Interestingly, our data demonstrated no signifi-
cant differences in TAD between patients with DCM
and SHF. Although both ventricular long-axis and
short-axis functions are jeopardized by cardiac dis-
eases, it is likely that long-axis function deteriorates
much earlier before short-axis function is affected
[25−27]. Thus, in an overwhelmed failing heart, lon-
gitudinal function may be severely impaired and fail
to make any difference regardless of cavity dilation.
TAD, a parameter reflecting longitudinal function,
may not be used to differentiate between patients
with DCM and SHF.
There are several limitations to our study. First,
the potential impact and extent of the hemodynamic
load on biventricular function reflected by TAD was
not assessed in our study. Future investigations focus-
ing on RV or LV with an acute pressure or volume
load on TAD may determine this issue. Second, our
tracking technique was only applicable for longitu-
dinal tracking, and therefore, both circumferential
and radial cardiac mechanics were not feasible in
this study. Third, the time differences in terms of
interventricular asynchrony based on TAD assess-
ment may also play a role in understanding the full
spectrum of heart failure pathophysiology but was
not addressed in our study.
Conclusion
Our data suggested that automatic TAD, an objec-
tive assessment of right ventricular longitudinal func-
tion, could be clinically feasible and easily applied,
not only in the adjunctive assessment of biventric-
ular systolic functional evaluation, but also in pre-
dicting earlier stage heart failure. In addition, we
found that cardiac longitudinal contraction worsen
indicating subclinical dysfunction, even in patients
with preserved LVEF.
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